Hemophilia Gene Therapy Wins FDA Nod – And Title of Priciest Drug Ever

CSL Behring has won FDA approval for Hemgenix (etranacogene dezaparvovec-drlb), a gene therapy with the potential to cure hemophilia B and — at $3.5 million per treatment — the most expensive drug in the world.
Source: Drug Industry Daily